High quality ELISAs
Developed and manufactured by Biomedica

Glaucoma is one of the leading causes of blindness worldwide, characterized by the loss of retinal ganglion cells (RGCs). Since vision loss from glaucoma is irreversible, early therapeutic intervention is critically important. However, due to current limitations in assessing glaucomatous neurodegeneration, it remains challenging to objectively monitor disease severity and progression, hindering the development of [...]

Study Reveals Reliable Measurement of NT-proBNP in Rats Using Biomedica ELISA Assay in Cardiac Overload Model We are pleased to share insights from a recent publication: " Platelet transfusion induces transfusion-associated circulatory overload in rats with myocardial infarction.” (1). This study provides valuable understanding of transfusion-related complications in cardiac injury models, with a particular focus [...]

The link between type 2 diabetes mellitus (T2DM) and bone fragility is complex. While individuals with type 2 diabetes often have normal to elevated bone mineral density, their risk of fractures is up to three times higher (1, 2). Understanding Bone Health in Type 2 Diabetes Recent research has shed new light on the complex [...]